Lipase Inhibitors
The present invention provides lipase inhibitors containing dimers having an epigallocatechin gallate (EGCG) unit derived from teas as well as foods and beverages and medicines containing said inhibitors. More specifically, the present invention provides lipase inhibitors containing at least one of proanthocyanidins represented by the formula: wherein R 1 and R 2 independently represent H or OH, and R 3 and R 4 independently represent H or a galloyl group; as well as foods and beverages and pharmaceutical compositions containing said lipase inhibitors.
1 . A lipase inhibitor containing at least one of proanthocyanidins represented by the formula:
wherein R 1 and R 2 independently represents H or OH, and R 3 and R 4 independently represent H or a galloyl group.
2 . The lipase inhibitor of claim 1 wherein the proanthocyanidin is selected from the group consisting of:
procyanidin B-2,
procyanidin B-3,
prodelphinidin A-2 3′-O-gallate,
prodelphinidin B-2,
prodelphinidin B-2 3′-O-gallate,
prodelphinidin B-2 3,3′-di-O-gallate,
prodelphinidin B-4,
prodelphinidin B-4 3′-O-gallate,
prodelphinidin B-5 3,3′-di-O-gallate,
(−)-epicatechin(4β-8)(−)-epigallocatechin 3-O-gallate,
(−)-epicatechin 3-O-gallate(4β-8)(−)-epigallocatechin 3-O-gallate,
(−)-epigallocatechin(4β-8)(−)-epicatechin 3-O-gallate,
(−)-epigallocatechin 3-O-gallate(4β-8)(−)-epicatechin 3-O-gallate,
(+)-catechin(4α-8)(−)-epigallocatechin,
(+)-catechin(4α-8)(−)-epigallocatechin 3-O-gallate, and
(+)-gallocatechin(4α-8)(−)-epicatechin.
3 . A food or beverage containing the lipase inhibitor of claim 1 .
4 . The food or beverage of claim 3 , which is selected from the group consisting of tea drinks, soft drinks and health foods.
5 . A pharmaceutical composition containing the lipase inhibitor of claim 1 .
6 . The pharmaceutical composition of claim 5 for inhibiting absorption of dietary fats.